Dr. Reddy's Laboratories (NYSE:RDY) Downgraded by StockNews.

Dr. Reddy's Laboratories (NYSE:RDY) Downgraded by StockNews.com

StockNews.com downgraded shares of Dr. Reddy’s Laboratories (NYSE:RDY – Free Report) from a strong-buy rating to a buy rating in a report published on Thursday. Separately, Barclays lifted their price objective on shares of Dr. Reddy’s Laboratories from $80.00 to $81.00 and gave the company an overweight rating in a research note on Wednesday, May […]

Related Keywords

Wellington , New Zealand General , New Zealand , , Barclays , Wellington Management Group , Sequoia Financial Advisors , Fisher Asset Management , Reddy Laboratories , Allspring Global Investments Holdings , Free Report , Global Investments Holdings , Financial Advisors , Management Group , Asset Management , Nordea Investment Management , Investment Management , Get Free Report , Laboratories Limited , Global Generics , Pharmaceutical Services , Active Ingredients , Laboratories Daily ,

© 2025 Vimarsana